These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
49. Synaptic trafficking of glutamate receptors by MAGUK scaffolding proteins. Elias GM; Nicoll RA Trends Cell Biol; 2007 Jul; 17(7):343-52. PubMed ID: 17644382 [TBL] [Abstract][Full Text] [Related]
50. Glutamate-stimulated release of norepinephrine in hippocampal slices of animal models of attention-deficit/hyperactivity disorder (spontaneously hypertensive rat) and depression/anxiety-like behaviours (Wistar-Kyoto rat). Howells FM; Russell VA Brain Res; 2008 Mar; 1200():107-15. PubMed ID: 18295191 [TBL] [Abstract][Full Text] [Related]
51. In search of novel AMPA potentiators. Francotte P; de Tullio P; Fraikin P; Counerotte S; Goffin E; Pirotte B Recent Pat CNS Drug Discov; 2006 Nov; 1(3):239-46. PubMed ID: 18221205 [TBL] [Abstract][Full Text] [Related]
52. AMPA receptor potentiators: application for depression and Parkinson's disease. O'Neill MJ; Witkin JM Curr Drug Targets; 2007 May; 8(5):603-20. PubMed ID: 17504104 [TBL] [Abstract][Full Text] [Related]
53. Therapeutic potential of positive AMPA receptor modulators in the treatment of neurological disease. Yamada KA Expert Opin Investig Drugs; 2000 Apr; 9(4):765-78. PubMed ID: 11060708 [TBL] [Abstract][Full Text] [Related]
54. Functional analysis of a novel positive allosteric modulator of AMPA receptors derived from a structure-based drug design strategy. Harms JE; Benveniste M; Maclean JK; Partin KM; Jamieson C Neuropharmacology; 2013 Jan; 64(1):45-52. PubMed ID: 22735771 [TBL] [Abstract][Full Text] [Related]
55. A novel series of positive modulators of the AMPA receptor: structure-based lead optimization. Jamieson C; Campbell RA; Cumming IA; Gillen KJ; Gillespie J; Kazemier B; Kiczun M; Lamont Y; Lyons AJ; Maclean JK; Martin F; Moir EM; Morrow JA; Pantling J; Rankovic Z; Smith L Bioorg Med Chem Lett; 2010 Oct; 20(20):6072-5. PubMed ID: 20817521 [TBL] [Abstract][Full Text] [Related]
56. Glutamate receptor plasticity at excitatory synapses in the brain. Genoux D; Montgomery JM Clin Exp Pharmacol Physiol; 2007 Oct; 34(10):1058-63. PubMed ID: 17714094 [TBL] [Abstract][Full Text] [Related]
57. Structure based evolution of a novel series of positive modulators of the AMPA receptor. Jamieson C; Maclean JK; Brown CI; Campbell RA; Gillen KJ; Gillespie J; Kazemier B; Kiczun M; Lamont Y; Lyons AJ; Moir EM; Morrow JA; Pantling J; Rankovic Z; Smith L Bioorg Med Chem Lett; 2011 Jan; 21(2):805-11. PubMed ID: 21190850 [TBL] [Abstract][Full Text] [Related]
58. Antipsychotic drugs reverse the AMPA receptor-stimulated release of 5-HT in the medial prefrontal cortex. Amargós-Bosch M; Adell A; Artigas F J Neurochem; 2007 Jul; 102(2):550-61. PubMed ID: 17394545 [TBL] [Abstract][Full Text] [Related]
59. The new 2,3-benzodiazepine derivative EGIS-8332 inhibits AMPA/kainate ion channels and cell death. Vegh MG; Kovács AD; Kovács G; Szabó G; Tihanyi K; Hársing LG; Lévay G Neurochem Int; 2007 Feb; 50(3):555-63. PubMed ID: 17147974 [TBL] [Abstract][Full Text] [Related]
60. AMPA receptor-mediated cell death is reduced by docosahexaenoic acid but not by eicosapentaenoic acid in area CA1 of hippocampal slice cultures. Ménard C; Patenaude C; Gagné AM; Massicotte G J Neurosci Res; 2009 Mar; 87(4):876-86. PubMed ID: 18951489 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]